Royalty Pharma plc (FRA:RPD)
31.98
0.00 (0.00%)
At close: Oct 23, 2025
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of €13.72 billion as of October 23, 2025. Its market cap has increased by 21.92% in one year.
Market Cap
13.72B
Enterprise Value
22.80B
Revenue
1.96B
Ranking
n/a
PE Ratio
15.79
Stock Price
€31.98
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has decreased from 14.00B to 13.72B, a decrease of -1.98%. That is a compound annual growth rate of -0.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2025 | 13.72B | 25.28% |
| Dec 31, 2024 | 10.95B | -3.17% |
| Dec 29, 2023 | 11.31B | -30.69% |
| Dec 30, 2022 | 16.31B | 8.38% |
| Dec 31, 2021 | 15.05B | -5.23% |
| Dec 31, 2020 | 15.88B | 13.43% |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 281.83B |
| Siemens Aktiengesellschaft | 185.73B |
| Deutsche Telekom AG | 139.77B |
| Allianz SE | 133.19B |
| Siemens Energy AG | 84.24B |
| Rheinmetall AG | 81.03B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 70.41B |
| Deutsche Bank Aktiengesellschaft | 54.96B |